Back to search

Peptide record

TPDB09620

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
20 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09620
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 iACP-DRLF Antifungipept CAFPdb
standard
No
A 20-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GLFTLIKGAYKLDAPTVACN
Physicochemical Analysis
C96H155N23O27S1
REQHMSW
AL
2095.48
8.86
2
1
10
+1
-0.36
0.545
107.50
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
1490
71.11
5
Residue Composition
number
3
A
0
R
1
N
1
D
1
C
0
E
0
Q
2
G
0
H
1
I
3
L
2
K
0
M
1
F
1
P
0
S
2
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 3 R: 0 N: 1 D: 1 C: 1 E: 0 Q: 0 G: 2 H: 0 I: 1 L: 3 K: 2 M: 0 F: 1 P: 1 S: 0 T: 2 W: 0 Y: 1 V: 1
Chemical Descriptors
20
C96H155N23O27S1
2095.48
8.86
+1
-0.36
0.545
Evidence Records 12 records
Evidence 1 Activity

Activity

MIC
Antibacterial
40.2 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against B. pyocyaneus (now P. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 2 Activity

Activity

MIC
Antibacterial
20.1 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

ive against B. pyocyaneus (now P. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 3 Activity

Activity

MIC
Antibacterial
20.1 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 4 Activity

Activity

MIC
Antifungal
40.2 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against B. pyocyaneus (now P. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 5 Activity

Activity

MIC
Antifungal
20.1 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ive against B. pyocyaneus (now P. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 6 Activity

Activity

MIC
Antifungal
20.1 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 7 Activity

Activity

MIC
Antiparasitic
40.2 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against B. pyocyaneus (now P. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 8 Activity

Activity

MIC
Antiparasitic
20.1 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

ive against B. pyocyaneus (now P. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 9 Activity

Activity

MIC
Antiparasitic
20.1 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 10 Activity

Activity

MIC
Antiviral
40.2 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against B. pyocyaneus (now P. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 11 Activity

Activity

MIC
Antiviral
20.1 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

ive against B. pyocyaneus (now P. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021
Evidence 12 Activity

Activity

MIC
Antiviral
20.1 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

. aeruginosa) (MIC 40.2 ug/ml), E. coli (MIC 40.2 ug/ml), S. aureus (MIC 20.1 ug/ml), and C. albicans (MIC 20.1 ug/ml). Updated 7/2021